Clinical Trial: Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension

U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07784296) titled 'Effectiveness and Safety of Sequential Triple Combination Therapy (Amlodipine/Losartan/Chlorthalidone) in Korean Patients With Hypertension' on July 28.

Brief Summary: A multicenter, prospective, non-interventional, observational study to evaluate effectiveness and safety of sequential triple combination therapy (amlodipine/losartan/chlorthalidone) in Korean patients with hypertension

Study Start Date: March 19

Study Type: OBSERVATIONAL

Condition: Hypertension

Intervention: DRUG: AMOPREL TAB 1.67/16.67/4.17mg

Follow-up of subjects prescribed medication in a non-intervention study

Recruitment Status: RECRUITING

Sponsor: Hanm...